MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-100 Resensitizes Resistant Chondrosarcoma Cells to Cisplatin through Direct Targeting of mTOR
Authors
Keywords
-
Journal
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 2, Pages 917-923
Publisher
Asian Pacific Organization for Cancer Prevention
Online
2014-07-01
DOI
10.7314/apjcp.2014.15.2.917
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Profiling of Receptor Tyrosine Kinases and Downstream Signaling in Human Chondrosarcomas Identifies Pathways for Rational Targeted Therapy
- (2013) Y.-X. Zhang et al. CLINICAL CANCER RESEARCH
- Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma
- (2013) Jolieke G. van Oosterwijk et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Analysis of microRNAs expressions in chondrosarcoma
- (2013) Teruhito Yoshitaka et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma
- (2013) Ping Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Diversifying microRNA sequence and function
- (2013) Stefan L. Ameres et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)
- (2013) Cora N. Sternberg et al. ONCOLOGY
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- PDCD5 promotes cisplatin-induced apoptosis of glioma cells via activating mitochondrial apoptotic pathway
- (2012) Haiyan S Li et al. CANCER BIOLOGY & THERAPY
- miRNA-100 Inhibits Human Bladder Urothelial Carcinogenesis by Directly Targeting mTOR
- (2012) C. Xu et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells
- (2011) Juan Wang et al. CELL CYCLE
- Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells
- (2011) Linda S. Steelman et al. CELL CYCLE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- MicroRNA and drug resistance
- (2010) J Ma et al. CANCER GENE THERAPY
- A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
- (2010) Ankur K. Nagaraja et al. MOLECULAR ENDOCRINOLOGY
- Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy
- (2009) Brian J. Henson et al. GENES CHROMOSOMES & CANCER
- Role of microRNA in anticancer drug resistance
- (2009) Tongsen Zheng et al. INTERNATIONAL JOURNAL OF CANCER
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- Consequences of Telomerase Inhibition by BIBR1532 on Proliferation and Chemosensitivity of Chondrosarcoma Cell Lines
- (2008) D. Parsch et al. CANCER INVESTIGATION
- Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro
- (2008) Yvonne M. Schrage et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Clinical Approach Towards Chondrosarcoma
- (2008) H. Gelderblom et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started